EVO Lipopeptides Platform
Autoimmune and Inflammatory Diseases (Dermatology, Ophthalmology, Respiratory)
Pre-clinicalActive
Key Facts
Indication
Autoimmune and Inflammatory Diseases (Dermatology, Ophthalmology, Respiratory)
Phase
Pre-clinical
Status
Active
Company
About Evora Biosciences
Evora Biosciences is a private, preclinical-stage biotech pioneering a novel therapeutic class of immunomodulatory lipopeptides. Its EVO platform aims to generate stable, non-toxic compounds with selective anti-inflammatory effects, positioning them as potential standalone or steroid-sparing treatments in high-need inflammatory diseases. The company is led by a small, experienced team and is supported by a network of industry partners, operating in a pre-revenue stage as it advances its platform towards clinical development.
View full company profile